Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of FibroGen Inc (NASDAQ: FGEN) closed at $1.14 in the last session, up 7.55% from day before closing price of $1.06. In other words, the price has increased by $7.55 from its previous closing price. On the day, 1.52 million shares were traded. FGEN stock price reached its highest trading level at $1.16 during the session, while it also had its lowest trading level at $1.02.
Ratios:
We take a closer look at FGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 12 ’24 when Adib Deyaa bought 22,123 shares for $1.17 per share. The transaction valued at 25,884 led to the insider holds 82,123 shares of the business.
Wettig Thane bought 50,000 shares of FGEN for $95,470 on Mar 07 ’24. The CEO now owns 470,178 shares after completing the transaction at $1.91 per share. On Sep 01 ’23, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 2,000 shares for $1.03 each. As a result, the insider received 2,060 and left with 28,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 113401952 and an Enterprise Value of 145170960. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68. Its current Enterprise Value per Revenue stands at 0.867 whereas that against EBITDA is -0.602.
Stock Price History:
The Beta on a monthly basis for FGEN is 0.74, which has changed by -0.5210084 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, FGEN has reached a high of $2.93, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 3.33%, while the 200-Day Moving Average is calculated to be -1.86%.
Shares Statistics:
According to the various share statistics, FGEN traded on average about 2.59M shares per day over the past 3-months and 2138230 shares per day over the past 10 days. A total of 98.77M shares are outstanding, with a floating share count of 92.39M. Insiders hold about 7.12% of the company’s shares, while institutions hold 61.95% stake in the company. Shares short for FGEN as of 1719532800 were 7319899 with a Short Ratio of 2.83, compared to 1717113600 on 7460849. Therefore, it implies a Short% of Shares Outstanding of 7319899 and a Short% of Float of 8.68.
